(Q44290404)

English

Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Sandro Ardizzone

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

P Paoluzi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

G D'Albasio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

A Pera

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

G Bianchi Porro

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

O A Paoluzi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

R Pica

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

M Miglioli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

C Prantera

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

G Sturniolo

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Digestive and Liver Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

787-793

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTc-labeled 5-ASA suppositories

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Aminosalicylic Acid as Enemas or Suppositories in Distal Ulcerative Colitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Aminosalicylates in inflammatory bowel disease: choosing the right dose

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biopsy studies in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term use of mesalamine enemas to induce remission in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesalazine induced interstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980072-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1590-8658(02)80072-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12546514%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44290404&oldid=2109187244"